Sana Biotechnology, Inc.
SANA
$3.20
-$0.06-1.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -25.28% | -30.83% | -26.88% | -26.86% | -18.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.21% | -29.66% | -35.91% | -30.33% | -39.23% |
| Operating Income | 16.21% | 29.66% | 35.91% | 30.33% | 39.23% |
| Income Before Tax | -15.96% | 8.47% | 23.35% | -2.97% | 32.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.96% | 8.47% | 23.35% | -2.97% | 32.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.96% | 8.47% | 23.35% | -2.97% | 32.38% |
| EBIT | 16.21% | 29.66% | 35.91% | 30.33% | 39.23% |
| EBITDA | 15.50% | 30.38% | 37.08% | 31.38% | 40.75% |
| EPS Basic | -6.14% | 16.65% | 31.16% | 7.58% | 42.12% |
| Normalized Basic EPS | 25.21% | 36.86% | 44.23% | 39.67% | 48.57% |
| EPS Diluted | -6.14% | 16.65% | 31.16% | 7.59% | 42.12% |
| Normalized Diluted EPS | 25.21% | 36.86% | 44.23% | 39.45% | 48.42% |
| Average Basic Shares Outstanding | 11.43% | 9.63% | 9.99% | 12.02% | 17.36% |
| Average Diluted Shares Outstanding | 11.43% | 9.63% | 9.99% | 11.56% | 16.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |